QTTB FY 2018 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$5M100.0% margin

Operating Income

-$60M-1126.0% margin

Net Income

-$56M-1044.3% margin

EPS (Diluted)

$-35.04

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$68M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$259M

Total Liabilities

$63M

Stockholders' Equity

$196M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$5M	-$684,214	+877.8%
Operating Income	-$60M	-$30M	-102.1%
Net Income	-$56M	-$30M	-85.3%